DiviScan — Global Health Intelligence Operating System USPTO Prov. #63/706,309
Sample Library — Trial Intelligence Reports & Evidence Decks Prepared: July 2026

← Back to DiviScan

Sample Library — Public Trial Intelligence Reports & Evidence Decks

Browse the Sample Portfolio Before Scoping

This page is the public sample portfolio for prospective paid engagements — every Trial Intelligence Report and evidence deck that ships as a public sample lives here. Read either sample end-to-end before scoping a pilot; that's the audit you should perform on the methodology before committing label-expansion conversation to it. The shape, narrative, and decision framing match what a paid engagement delivers: HyperCore's 320-classifier decomposition is the same stack used in Tier 1 paid pilots, so what you see in the samples is what ships from a paid engagement.

View the Trial Intelligence Report paid pilot offering → /trial-intelligence-report

Pre-handle procurement objections in the FAQ → /trial-intelligence-report/faq

Available Samples

TIR · TRIAL INTELLIGENCE REPORT

KEYNOTE-789 — Pembrolizumab Phase 3 NSCLC (OS endpoint)

HyperCore 320-classifier Kaplan-Meier decomposition of the KEYNOTE-789 phase 2/3 non-small-cell lung cancer (NSCLC) overall survival dataset. Responder/non-responder attribution at the month-9 inflection, classifier weighting, and post-ASCO label-expansion playbook.
Status: Live · last updated July 2026
Open sample report →
EVIDENCE DECK · DUE DILIGENCE

HyperCore 320-Classifier — Methodology & Validation Evidence

Tier 1 evidence package for pharma due diligence: HyperCore classifier methodology, MIMIC-IV validation signals, and the planned Open Science Framework (OSF) retrospective re-analysis scope.
Status: Live · last updated July 2026
Open evidence deck →

Scope a Paid Pilot

When you are ready to scope a Trial Intelligence Report pilot — on your trial, your comparator set, or a label-expansion question you are working — the paid pilot pitch is the starting point. Browse, then scope.

Open the Trial Intelligence Report paid pilot offering →